Literature DB >> 28688958

Novel derivatives of deoxycholic acid bearing aliphatic or cyclic diamine moieties at the C-3 position: Synthesis and evaluation of anti-proliferative activity.

Irina I Popadyuk1, Andrey V Markov2, Valeriya O Babich3, Oksana V Salomatina4, Evgeniya B Logashenko5, Marina A Zenkova6, Nariman F Salakhutdinov7.   

Abstract

A new library of deoxycholic acid derivatives bearing nitrogen-containing moieties at the C-3 position was synthesised from epoxy derivative 1 via an epoxide ring-opening reaction promoted by aliphatic or cyclic diamines and fully characterised by NMR and mass-spectroscopy. The synthesised compounds were screened for cytotoxicity against four human tumour cell lines. The results showed that some of the novel diamine-bearing derivatives displayed improved anti-proliferative activities over the parent compound DCA. Among them, a 1-methylpiperazine containing compound (6) showed promising activity and the highest selectivity against tumour cells of enterohepatic origin (HepG2: IC50=3.6µM, SI=9.0; HuTu-80: IC50=4.6µM, SI=6.9) and was identified as a lead molecule.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-proliferative activity; Cytotoxicity; Deoxycholic acid derivatives; Diamines; Epoxides

Mesh:

Substances:

Year:  2017        PMID: 28688958     DOI: 10.1016/j.bmcl.2017.06.072

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Microwave-assisted green synthesis of bile acid derivatives and evaluation of glucocorticoid receptor binding.

Authors:  Bojana R Vasiljević; Edward T Petri; Sofija S Bekić; Andjelka S Ćelić; Ljubica M Grbović; Ksenija J Pavlović
Journal:  RSC Med Chem       Date:  2020-11-19

2.  N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry.

Authors:  A A Kononova; A S Sokolova; S V Cheresiz; O I Yarovaya; R A Nikitina; A A Chepurnov; A G Pokrovsky; N F Salakhutdinov
Journal:  Medchemcomm       Date:  2017-10-19       Impact factor: 3.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.